Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share Price

Price 2,144.00p on 20-04-2026 at 17:50:07
Change 0.00p 0%
Buy 2,145.00p
Sell 2,144.00p
Last Trade: Unknown 438,696.00 at 2,145.00p
Day's Volume: 4,715,270
Last Close: 2,144.00p
Open: 2,145.00p
ISIN: GB00BN7SWP63
Day's Range 2,134.00p - 2,156.00p
52wk Range: 1,315.00p - 2,282.00p
Market Capitalisation: £85.63b
VWAP: 2,143.58036p
Shares in Issue: 3.99b

Glaxosmithkline (GSK) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 438,696 2,145.00p OTC Trade
17:08:52 - 20-Apr-26
Unknown* 438,696 2,145.00p OTC Trade
17:08:52 - 20-Apr-26
Sell* 237 2,143.50p SI Trade
Suspected SELL Trade
17:04:57 - 20-Apr-26
Sell* 714 2,144.00p SI Trade
Suspected SELL Trade
16:48:11 - 20-Apr-26
Sell* 443 2,144.00p SI Trade
Suspected SELL Trade
16:48:11 - 20-Apr-26
Sell* 23,196 2,142.963p SI Trade
Suspected SELL Trade
16:47:06 - 20-Apr-26
Buy* 646 2,144.00p Automatic Execution
16:37:29 - 20-Apr-26
Buy* 2,000 2,144.00p Automatic Execution
16:37:29 - 20-Apr-26
Buy* 57 2,144.00p SI Trade
16:35:29 - 20-Apr-26
Buy* 217 2,144.00p SI Trade
16:35:29 - 20-Apr-26
See more Glaxosmithkline trades

Glaxosmithkline (GSK) Share Price History

Time period:
to
Date Open High Low Close Volume
17th Apr 2026 (Fri) 2,122.00 2,144.00 2,115.00 2,144.00 5,135,113
16th Apr 2026 (Thu) 2,121.00 2,135.00 2,115.00 2,123.00 4,358,573
15th Apr 2026 (Wed) 2,198.00 2,202.00 2,131.00 2,131.00 6,008,590
14th Apr 2026 (Tue) 2,170.00 2,195.00 2,164.00 2,190.00 4,785,341
13th Apr 2026 (Mon) 2,151.00 2,180.00 2,151.00 2,170.00 6,947,099
10th Apr 2026 (Fri) 2,156.00 2,196.00 2,156.00 2,176.00 8,127,125
9th Apr 2026 (Thu) 2,141.00 2,167.00 2,124.00 2,167.00 6,632,002
8th Apr 2026 (Wed) 2,126.00 2,142.00 2,104.00 2,125.00 9,481,975
7th Apr 2026 (Tue) 2,129.00 2,137.00 2,083.00 2,096.00 5,857,080
6th Apr 2026 (Mon) 2,144.00 2,144.00 2,144.00 2,144.00 0
3rd Apr 2026 (Fri) 2,144.00 2,144.00 2,144.00 2,144.00 0
2nd Apr 2026 (Thu) 2,097.00 2,161.00 2,090.00 2,144.00 6,448,889
1st Apr 2026 (Wed) 2,072.00 2,122.00 2,072.00 2,107.00 6,204,094
31st Mar 2026 (Tue) 2,064.00 2,086.00 2,064.00 2,064.00 15,704,368
30th Mar 2026 (Mon) 2,051.00 2,070.00 2,044.00 2,063.00 9,872,668
27th Mar 2026 (Fri) 2,041.00 2,060.00 2,023.00 2,049.00 6,240,777
26th Mar 2026 (Thu) 2,035.00 2,072.00 2,035.00 2,047.00 12,704,366
25th Mar 2026 (Wed) 1,991.50 2,054.00 1,989.50 2,054.00 11,609,628
24th Mar 2026 (Tue) 1,943.50 1,977.00 1,933.00 1,977.00 7,832,345
23rd Mar 2026 (Mon) 1,926.00 1,966.50 1,906.50 1,937.00 12,420,260
20th Mar 2026 (Fri) 1,960.00 1,967.50 1,940.50 1,950.50 14,988,054
See more Glaxosmithkline price history

Glaxosmithkline (GSK) Regulatory News

Date Source Headline
17th Apr 2026 7:00 am RNS Transaction in Own Shares
16th Apr 2026 3:30 pm RNS Director/PDMR Shareholding
16th Apr 2026 7:00 am RNS Transaction in Own Shares
15th Apr 2026 7:12 am RNS GSK completes acquisition of 35Pharma Inc.
15th Apr 2026 7:00 am RNS Transaction in Own Shares
14th Apr 2026 3:30 pm RNS Director/PDMR Shareholding
14th Apr 2026 7:00 am RNS Transaction in Own Shares
13th Apr 2026 3:30 pm RNS Director/PDMR Shareholding
13th Apr 2026 7:00 am RNS Transaction in Own Shares
13th Apr 2026 7:00 am RNS GSK presents positive data for BEHOLD 1 B7 H4 ADC
See more Glaxosmithkline regulatory news

Glaxosmithkline (GSK) Share News

GSK wins China approval for Blenrep for refractory multiple myeloma

20th Apr 2026 08:47

(Alliance News) - GSK PLC on Monday said the National Medical Products Administration of China has approved Blenrep in combination with bortezomib and dexamethasone in the treatment of adults with relapsed or refractory multiple myeloma. Read More

LONDON BRIEFING: Kainos guides revenue beat; Evoke in takeover talks

20th Apr 2026 07:56

(Alliance News) - Plus500 expects 2026 earnings to beat current expectations, Advanced Medical Solutions and Evoke separately confirm takeover talks and Auction Technology says its long-standing chief executive officer will step down soon. Read More

LONDON MARKET CLOSE: Traders weigh war deadlock; luxury woes hit Paris

15th Apr 2026 17:02

(Alliance News) - The FTSE 100 fell on Wednesday as investors awaited a hoped for resumption in peace talks between the US and Iran. Read More

GSK completes purchase of Canada's 35Pharma for USD950 million

15th Apr 2026 10:33

(Alliance News) - GSK PLC on Wednesday said it has completed the acquisition of Canada-based clinical stage biopharmaceutical firm 35Pharma Inc for USD950 million in cash. Read More

LONDON BROKER RATINGS: Bernstein cuts Wizz Air and easyJet

13th Apr 2026 09:39

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More

See more Glaxosmithkline news
FTSE 100 Latest
Value10,609.08
Change-58.55

Login to your account

Forgot Password?

Not Registered